Vivos Therapeutics与Streeterville已同意延长双方战略融资协议的执行时间框架。与此同时,两家公司再次确认了将既有债务转换为Vivos普通股及永续优先股的核心承诺。此举旨在为双方的战略合作提供更充裕的规划与执行空间,确保融资安排能够顺利推进,并进一步稳固公司的资本结构。
Vivos Therapeutics与Streeterville已同意延长双方战略融资协议的执行时间框架。与此同时,两家公司再次确认了将既有债务转换为Vivos普通股及永续优先股的核心承诺。此举旨在为双方的战略合作提供更充裕的规划与执行空间,确保融资安排能够顺利推进,并进一步稳固公司的资本结构。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.